Update date
30 Jun 2021
Shareable Research Card
QNRX - Quoin Pharmaceuticals, Ltd. Equity
This metric view shows QNRX - Quoin Pharmaceuticals, Ltd. equity history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q2 2021
- Latest reported value
- $1,755,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2021
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q2 2021.
- Latest reported value on this page: $1,755,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Equity
Latest reported equity: $1,755,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q2 2021
SEC-backed company facts were refreshed from filings filed on 07 May 2026.
Benchmark Context
How Equity compares with peers
Quoin Pharmaceuticals, Ltd. sits in the bottom quarter of the current equity sample.
Compared with
Compared with 39 companies reporting equity in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Equity does not yet have enough prior-period data for a historical comparison on this page.
- Visible rows currently span reported period ends from 31 Dec 2017 to 30 Sep 2025.
- Nearby companies in this sample: CollPlant Biotechnologies Ltd and Nexera Technologies Ltd.
- Current sample position: rank #32 of 39 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Quoin Pharmaceuticals, Ltd.: Equity
Latest period: Q2 2021. Period end: 30 Jun 2021. Units: USD and ILS. Frequency: quarterly.
Equity is reported in company XBRL facts filed with the SEC.
Metric snapshot
- Latest value
- $1,755,000
- Coverage range
- 31 Dec 2016 - 30 Jun 2021
- Fact rows
- 14
What this metric tells you
- Shows reported equity over 31 Dec 2016 - 30 Jun 2021.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 14 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Quoin Pharmaceuticals, Ltd. appears at rank #32 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | CRH PUBLIC LTD CO (crh) | $22,337,000,000 | Instant - 31 Dec 2022 | Open CRH PUBLIC LTD CO Equity |
| 2 | Flutter Entertainment plc (flut) | $4,519,443,000 | Instant - 31 Dec 2019 | Open Flutter Entertainment plc Equity |
| 3 | SSR MINING INC. (ssrm) | $3,939,903,000 | Instant - 31 Dec 2020 | Open SSR MINING INC. Equity |
| 4 | Curaleaf Holdings, Inc. (curlf) | $1,798,847,000 | Instant - 31 Dec 2021 | Open Curaleaf Holdings, Inc. Equity |
| 5 | CELESTICA INC (cls) | $1,768,500,000 | Instant - 31 Dec 2023 | Open CELESTICA INC Equity |
| 6 | Burford Capital Ltd (bur) | $1,661,580,000 | Instant - 31 Dec 2020 | Open Burford Capital Ltd Equity |
Metric Details
- Metric
- Equity (Equity)
- Frequency coverage
-
quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- ifrs-full
- Units tracked
- USD and ILS
- History range
-
31 Dec 2016 - 30 Jun 2021
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
14
Source: SEC company facts API
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Equity, Quarterly (USD)
Equity, YoY Quarterly Change (%)
Equity, Quarterly (ILS)
Equity, YoY Quarterly Change (%)
Quoin Pharmaceuticals, Ltd. Quarterly Equity (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2021 | $1,755,000 | 30 Jun 2021 | 6-K | 24 Aug 2021 | 2021 | Q2 | ||
| Q4 2020 | $4,659,000 | +$366,000 | +8.5% | 31 Dec 2020 | 20-F | 29 Mar 2021 | 2020 | FY |
| Q4 2019 | $4,293,000 | 31 Dec 2019 | 20-F | 03 Apr 2020 | 2019 | FY | ||
| Q2 2018 | $6,060,000 | 30 Jun 2018 | 6-K | 09 Aug 2018 | 2018 | Q2 | ||
| Q4 2017 | $5,438,000 | 31 Dec 2017 | 20-F | 19 Mar 2018 | 2017 | FY |
Quoin Pharmaceuticals, Ltd. Quarterly Equity (ILS)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2021 | ₪5,723,000 | -₪16,068,000 | -74% | 30 Jun 2021 | 6-K | 24 Aug 2021 | 2021 | Q2 |
| Q4 2020 | ₪14,980,000 | +₪143,000 | +0.96% | 31 Dec 2020 | 6-K | 24 Aug 2021 | 2021 | Q2 |
| Q2 2020 | ₪21,791,000 | -₪117,000 | -0.53% | 30 Jun 2020 | 6-K/A | 11 Feb 2021 | 2020 | Q2 |
| Q4 2019 | ₪14,837,000 | +₪914,000 | +6.6% | 31 Dec 2019 | 6-K | 24 Aug 2021 | 2021 | Q2 |
| Q2 2019 | ₪21,908,000 | -₪211,000 | -0.95% | 30 Jun 2019 | 6-K | 13 Aug 2019 | 2019 | Q2 |
| Q4 2018 | ₪13,923,000 | -₪4,929,000 | -26% | 31 Dec 2018 | 20-F | 29 Mar 2021 | 2020 | FY |
| Q2 2018 | ₪22,119,000 | 30 Jun 2018 | 6-K | 09 Aug 2018 | 2018 | Q2 | ||
| Q4 2017 | ₪18,852,000 | -₪9,635,000 | -34% | 31 Dec 2017 | 20-F | 29 Mar 2021 | 2020 | FY |
| Q4 2016 | ₪28,487,000 | 31 Dec 2016 | 20-F | 03 Apr 2020 | 2019 | FY |
* marks a reported value that did not pass the local value check.